Hunting Hill Global Capital’s Avidity Biosciences RNAM Stock Holding History

Hunting Hill Global Capital’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,937	Closed	-$212K	–	125
2025 Q4	$212K	Buy	+2,937	New	+$190K	0.15%	85

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Hunting Hill Global Capital's RNAM Position: Q1 2026 in Review

Hunting Hill Global Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,937 shares — an estimated $212K sold.

Hunting Hill Global Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $212K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Hunting Hill Global Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Hunting Hill Global Capital sold 2,937 Avidity Biosciences shares in Q1 2026, an estimated $212K.
Hunting Hill Global Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Hunting Hill Global Capital's Avidity Biosciences position peaked at $212K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Hunting Hill Global Capital's 13F filing for Q1 2026, filed 15 May 2026.